NASDAQ:AMGN
$241.75
(
0.104%
)
Friday, 31st Mar 2023
Amgen Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $225.40 | $242.81 | Friday, 31st Mar 2023 AMGN stock ended at $241.75. This is 0.104% more than the trading day before Thursday, 30th Mar 2023. During the day the stock fluctuated 1.36% from a day low at $239.15 to a day high of $242.40. |
| 90 days | $225.40 | $276.84 | |
| 52 weeks | $223.30 | $296.67 |
Historical Amgen Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-03-31 | $241.43 | $242.40 | $239.15 | $241.75 | 2 762 481 |
| 2023-03-30 | $242.53 | $242.81 | $240.11 | $241.50 | 2 576 875 |
| 2023-03-29 | $239.71 | $241.59 | $238.33 | $241.03 | 2 741 853 |
| 2023-03-28 | $237.00 | $238.68 | $236.91 | $238.48 | 1 887 756 |
| 2023-03-27 | $239.61 | $239.95 | $235.07 | $236.76 | 2 128 793 |
| 2023-03-24 | $234.22 | $238.50 | $233.01 | $238.03 | 2 545 670 |
| 2023-03-23 | $230.04 | $234.10 | $229.89 | $233.10 | 2 175 380 |
| 2023-03-22 | $233.45 | $233.95 | $229.59 | $229.83 | 1 724 804 |
| 2023-03-21 | $234.72 | $235.28 | $231.04 | $232.95 | 2 128 631 |
| 2023-03-20 | $230.58 | $235.16 | $230.14 | $234.72 | 2 020 779 |
| 2023-03-17 | $233.57 | $233.81 | $228.52 | $229.79 | 7 817 232 |
| 2023-03-16 | $233.74 | $234.66 | $230.06 | $234.57 | 2 326 034 |
| 2023-03-15 | $230.40 | $235.57 | $228.55 | $234.90 | 2 964 917 |
| 2023-03-14 | $233.46 | $233.46 | $229.41 | $230.58 | 3 227 095 |
| 2023-03-13 | $231.18 | $237.27 | $230.50 | $233.18 | 3 145 465 |
| 2023-03-10 | $226.77 | $230.28 | $225.63 | $227.87 | 2 647 235 |
| 2023-03-09 | $229.49 | $229.83 | $225.40 | $225.79 | 1 728 597 |
| 2023-03-08 | $230.16 | $231.80 | $227.37 | $228.43 | 1 830 147 |
| 2023-03-07 | $235.11 | $235.20 | $228.35 | $228.72 | 2 344 088 |
| 2023-03-06 | $235.00 | $235.63 | $233.64 | $235.11 | 2 506 740 |
| 2023-03-03 | $235.00 | $235.89 | $233.60 | $234.81 | 1 979 024 |
| 2023-03-02 | $236.12 | $236.37 | $233.90 | $234.74 | 1 745 800 |
| 2023-03-01 | $230.37 | $236.44 | $230.14 | $236.19 | 2 419 812 |
| 2023-02-28 | $233.63 | $234.47 | $231.60 | $231.66 | 2 597 853 |
| 2023-02-27 | $235.22 | $235.22 | $232.89 | $234.45 | 1 685 964 |
| 2023-02-24 | $236.83 | $237.06 | $233.12 | $233.66 | 1 853 499 |
| 2023-02-23 | $236.70 | $237.86 | $234.75 | $237.62 | 2 211 585 |
| 2023-02-22 | $240.30 | $240.99 | $235.75 | $236.16 | 2 187 082 |
| 2023-02-21 | $240.79 | $241.92 | $238.20 | $238.24 | 2 524 481 |
| 2023-02-17 | $235.34 | $241.72 | $233.71 | $240.53 | 2 924 853 |
| 2023-02-16 | $238.46 | $239.01 | $234.04 | $234.22 | 3 289 723 |
| 2023-02-15 | $240.21 | $240.54 | $238.73 | $240.07 | 1 780 678 |
| 2023-02-14 | $242.70 | $243.00 | $239.11 | $241.03 | 2 007 737 |
| 2023-02-13 | $243.20 | $243.83 | $241.30 | $243.66 | 2 319 931 |
| 2023-02-10 | $241.92 | $244.14 | $240.41 | $242.50 | 2 687 076 |
| 2023-02-09 | $241.12 | $243.46 | $238.99 | $240.00 | 3 018 491 |
| 2023-02-08 | $242.99 | $243.56 | $239.60 | $240.20 | 2 705 146 |
| 2023-02-07 | $243.02 | $244.94 | $241.42 | $244.00 | 2 407 444 |
| 2023-02-06 | $245.36 | $246.80 | $243.45 | $243.85 | 2 196 326 |
| 2023-02-03 | $249.96 | $249.96 | $242.21 | $245.17 | 3 072 241 |
| 2023-02-02 | $243.78 | $246.57 | $236.37 | $246.53 | 5 484 111 |
| 2023-02-01 | $249.16 | $249.55 | $240.00 | $246.41 | 5 306 152 |
| 2023-01-31 | $253.86 | $253.86 | $249.89 | $252.40 | 3 403 720 |
| 2023-01-30 | $253.46 | $254.16 | $250.60 | $251.59 | 2 039 802 |
| 2023-01-27 | $254.87 | $255.50 | $252.54 | $253.65 | 2 109 728 |
| 2023-01-26 | $256.54 | $256.69 | $253.01 | $254.88 | 2 518 596 |
| 2023-01-25 | $260.09 | $261.55 | $256.02 | $256.54 | 1 899 203 |
| 2023-01-24 | $261.85 | $262.00 | $257.52 | $259.70 | 1 589 892 |
| 2023-01-23 | $264.00 | $264.73 | $259.81 | $260.97 | 2 024 030 |
| 2023-01-20 | $262.03 | $263.84 | $259.87 | $263.24 | 2 574 116 |
About Amgen Inc.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
